| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CMO | COO & VP of Product Dev
1 company
Stephanie Morley last filed a Form 4 in April 2021, as President & CMO at ZOMDF. Stephanie Morley's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,459,580 shares of ZOMDF. The ZOMDF filings lean toward selling, a net 805,000 shares.
Stephanie Morley has 7 Form 4 filings on record from March 2018 to April 2021, all as President & CMO at Zomedica (ZOMDF), 2018–2021.
The 10 reported transactions were 4 option exercises, 4 option or other derivative awards and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $931K.
The only open-market sale was 805,000 shares of ZOMDF at an average $1.16 on April 12, 2021, about $931K.
Shares as reported in the last Form 4 for each company; the most recent is from April 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2021 | ZOMDF Zomedica Corp. | President & CMO | Sale+OE | 805,000 | $1.16 | $931,143.50 | -35.5% |